(No ratings)
Dr. Samareh Cunningham Azar, MD is an ophthalmologist in Tyler, TX specializing in ophthalmology (eye disease) and general ophthalmology. She graduated from Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine. Dr. Samareh Cunningham Azar, MD is affiliated with CHRISTUS Health, EAST TEXAS EYE CARE ASSOCIATES PLLC and Eyecare Associates of East Texas.
Dr. Samareh Cunningham Azar, MD graduated from Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine. She completed residency at University of Cincinnati Affiliated Hospitals. She has a state license in Texas.
Medical School: Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine
Residency: University of Cincinnati Affiliated Hospitals
Licensed In: Texas
Dr. Samareh Cunningham Azar, MD is associated with these hospitals and organizations:
Dr. Samareh Cunningham Azar, MD does not have any reviews yet, be the first to leave a review of Dr. Samareh Cunningham Azar, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Samareh Cunningham Azar, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Alcon Vision LLC |
$614
Hydrus Microstent $266 |
CLAREON $164 |
Centurion $82 |
WaveLight EX500 Excimer Laser $75 |
Wavelight Refractive Suite $27 |
|---|---|---|---|---|---|
| BIOTISSUE HOLDINGS, INC. |
$164
AmnioGraft $164 |
||||
| Sight Sciences, Inc. |
$130
OMNI Surgical System $130 |
||||
| Apellis Pharmaceuticals, Inc. |
$125
SYFOVRE $125 |
||||
| Astellas Pharma US Inc |
$100
Izervay $100 |
| Food and Beverage | $1,133 |
|---|
Dr. Samareh Azar is a general ophthalmology specialist. She attended medical school at Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine. Her training includes a residency program at a hospital affiliated with the University of Cincinnati. Dr. Azar is affiliated with CHRISTUS Health. She has an open panel in Tyler, TX according to Yext.